Status:
RECRUITING
Illuminating New Paths in the Treatment of Multiple Sclerosis Relapses - Early and Specialized Rehabilitation
Lead Sponsor:
Lars Hvid
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The overall purpose of this project is to develop and test an infrastructure that can ensure early and specialized rehabilitation for individuals with multiple sclerosis (MS) on their path to recovery...
Eligibility Criteria
Inclusion
- admitted to the Danish MS Hospitals for an inpatient rehabilitation stay
- confirmed motor relapse (within the past 6 months) by a neurologist, with disability/ functional interference characterized by change in pyramidal, and/or cerebellar functional scores of 2 or higher
- completed steroid or other acute relapse treatment, if prescribed
- age over 18 years
Exclusion
- more than 6 months since onset of motor relapse
- medical conditions or substantial cognitive impairments that hinder participation in the study (e.g. inability to perform or understand the intensive rehabilitation)
- pregnancy
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT06956326
Start Date
May 1 2025
End Date
December 31 2027
Last Update
May 4 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The Danish MS Hospitals
Haslev, Denmark, 7080
2
The Danish MS Hospitals
Ry, Denmark, 7080